In addition, amplification of CDK6, MYCN and SNCAP1 as well as aberrant ERBB4-SRC signaling and nuclear factor kappa B (NF-κB) have also been observed in Group 4 medulloblastoma (3–6, 19, 21, 22). Here, MYCN is linked to medulloblastoma.